Heartburn and Mucosal Barrier Weakness

  • J. J. Bernier
  • Ch. Florent
Conference paper

Abstract

Most of the patients who suffer from illness of the digestive tract do not show any signs of lesion after a careful examination. They are classified as “dyspentic” or of “psychosomatic” patients; many cases seem to have a functional disorder somewhere in the digestive tract. Our aim is to show that some patients have a mucosal defect which we shall call “mucosal barrier weakness.” The rationale of this hypothetic mechanism is:
  1. 1.

    Experimental cytoaggression by different drugs is clearly established.

     
  2. 2.

    The major symptom of many dyspeptic patients is epigastric heartburn (quite different from pyrosis, which is a retrosternal and ascending pain), which appears shortly after ingestion of some beverages (white wine, coffee) or meals (jam or spices). These nutrients may possibly act as cytoaggressors.

     
  3. 3.

    We have found [2] in normal subjects that montmorrillonnite, an inert and neutral clay, reduces the aggressive effect of aspirin not only when they are both ingested at the same time, but also when aspirin is ingested 24 h after the clay (Tarnasky et al. have observed the same with glucagon [8]).

     
  4. 4.

    According to the general law linking pathological and physiological mechanisms (the first being either an enhancement or a diminution of the second), one may hypothesize that if some substances are able to increase the resistance of the mucosa, some others could produce the opposite: a weakening of the mucosal barrier.

     

Keywords

Clay Catheter Aspirin Prostaglandin Palladium 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Blum A, Heartburn and gastrooesophageal reflux. Personal communicationGoogle Scholar
  2. 2.
    Florent C, Flourie B, Bernier JJ (1985) Effets d’un pansement anti-acide sur les modifications de la différence de potential gastrique induite par l’aspirine chez l’homme. Gastroenterol Clin Biol 8: 359–363Google Scholar
  3. 3.
    Florent C, Flourie B, Pfeiffer A, Bernier JJ (1985) Mesure de la différence de potential transépitheliale gastrique. Gastroenterol Clin Biol 9: 58–64PubMedGoogle Scholar
  4. 4.
    Florent C, Pfeiffer A, Bernier JJ (1985) La faiblesse de la barrière muqueuse gastrique: un nouveau concept. Gastroenterol Clin Biol 9: 65–71PubMedGoogle Scholar
  5. 5.
    Jorgensen LS, Bonlokke L, Wamberg P (1985) Non-ulcer upper dyspepsia. Aspect of pain. Scand J Gastroenterol 20: 46–50CrossRefGoogle Scholar
  6. 6.
    Kingham GC, Dawson AM (1985) Origin of chronic right upper quadrant pain. Gut 26: 783–788Google Scholar
  7. 7.
    Malagelada J (1986) Dyspepsia, Workshop World Congress São PauloGoogle Scholar
  8. 8.
    Tarnawski A, Krause WJ, Kevin JI (1978) Effect of glucagon on aspirin-induced gastric mucosal damage in man. Gastroenterology 74: 240–245PubMedGoogle Scholar
  9. 9.
    Trump BF, Mac Dowell EM (1976) Histologic fixatives suitable for diagnostic light and electron microscopy. Arch Path Lab Med 100: 405–414PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • J. J. Bernier
  • Ch. Florent

There are no affiliations available

Personalised recommendations